Debt-to-equity of TransMedics Group, Inc. from 28 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
TransMedics Group, Inc. quarterly Debt-to-equity in % history and change rate from 28 Sep 2019 to 30 Sep 2025.
  • TransMedics Group, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 198%, a 40% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

TransMedics Group, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 198% -129% -40% 30 Sep 2025
Q2 2025 224% -145% -39% 30 Jun 2025
Q1 2025 256% -138% -35% 31 Mar 2025
Q4 2024 290% -5% -1.5% 31 Dec 2024
Q3 2024 327% +129% +65% 30 Sep 2024
Q2 2024 369% +255% +223% 30 Jun 2024
Q1 2024 394% +340% +623% 31 Mar 2024
Q4 2023 294% +231% +366% 31 Dec 2023
Q3 2023 198% +121% +155% 30 Sep 2023
Q2 2023 114% +17% +18% 30 Jun 2023
Q1 2023 55% -25% -32% 31 Mar 2023
Q4 2022 63% -3% -4% 31 Dec 2022
Q3 2022 78% +23% +43% 30 Sep 2022
Q2 2022 97% +48% +97% 30 Jun 2022
Q1 2022 80% +34% +73% 31 Mar 2022
Q4 2021 66% +13% +25% 31 Dec 2021
Q3 2021 54% -7% -12% 30 Sep 2021
Q2 2021 49% -22% -31% 30 Jun 2021
Q1 2021 46% -39% -46% 31 Mar 2021
Q4 2020 53% +2112% 31 Dec 2020
Q3 2020 62% +139% 30 Sep 2020
Q2 2020 72% 30 Jun 2020
Q1 2020 85% 31 Mar 2020
Q4 2019 -2060% 28 Dec 2019
Q3 2019 -77% 28 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.